Jazz Pharmaceuticals (JAZZ) Gross Profit Growth (3y) (2013 - 2026)
Jazz Pharmaceuticals (JAZZ) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 54.36% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.16% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.86% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.18% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.75 Bn | 13.91 Bn | 934.80 Mn | 6.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.95% |
| Dec 31, 2025 | 9.08% |
| Sep 30, 2025 | 7.31% |
| Jun 30, 2025 | 4.75% |
| Mar 31, 2025 | 4.33% |
| Dec 31, 2024 | 8.05% |
| Sep 30, 2024 | 10.83% |
| Jun 30, 2024 | 13.05% |
| Mar 31, 2024 | 12.44% |
| Dec 31, 2023 | 13.71% |
| Sep 30, 2023 | 16.17% |
| Jun 30, 2023 | 17.49% |
| Mar 31, 2023 | 15.07% |
| Dec 31, 2022 | 13.78% |
| Sep 30, 2022 | 17.23% |
| Jun 30, 2022 | 17.72% |
| Mar 31, 2022 | 14.13% |
| Dec 31, 2021 | 19.11% |
| Sep 30, 2021 | 16.46% |
| Jun 30, 2021 | 11.09% |